Germany plans to extend pharma price freeze, rebates
This article was originally published in Scrip
Executive Summary
Despite the large and growing surplus in the health insurance accounts, the incoming German government is planning to extend the freeze on pharmaceutical prices beyond the end of this year. It also intends to continue with mandatory rebate contracts on drug sales to the statutory health insurance, albeit at a lower rate.